Catto - Figure 25
Active Surveillance
FIG. 25: The meager returns for active surveillance of these patients are especially hard to justify if one recognizes that even if a local recurrence is diagnosed, it can be managed back to a level needing only surveillance and conservative measures.[25,26]
References
[25]
Thomas JS, Crew J. Active surveillance for bladder cancer. Oncol News. 2011;6:88−90
[26]
Mariappan P, Smith G. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. J Urol. 2005;173:1108−11 https://doi.org/10.1097/01.ju.0000149163.08521.69
